Stock Market Analysis & Opinion

Tesla's market capitalization slumped after Elon Musk announced Twitter interest To reduce risk, Musk has secured new financing Some analysts think the deal could be a big distraction for Tesla's...

This article was written exclusively for Investing.comWe’ve all seen a lot of things change over the last two-and-a-half years since the first time we heard about COVID-19. Some changes such as...

Norwegian Cruise Line stock is down by about 7% since January Wall Street is concerned strong pent-up demand will be overshadowed by costs, geopolitical concerns Long-term investors could consider...

It's not an exaggeration to say that, right now, Comcast (NASDAQ:CMCSA) stock is everything that investors don't like. Even relative to a steep market sell-off over the past few weeks, the sectors in...

The Shell (LON:SHEL) share price has been one of the best performers this year on the FTSE 100, and today’s Q1 numbers have served to illustrate why, as the company followed in the footsteps of...

Airbnb gave a robust sales forecast for the current quarter The booking app predicts “substantial demand” ahead of the busy summer season Despite travel rebound, macroeconomic headwinds...

Snap shares have lost about 39% so far in 2022 Recent metrics show a growing user base for the social media platform Despite current volatility, long-term investors could consider buying the stock at...

The cloud software-as-a-service (SaaS) industry has gotten off to a tumultuous start in 2022, with the tech sector’s two main ETFs lagging the comparable returns of the NASDAQ Composite by a...

Earlier today, I used the InvestingPRO subscription tool, to do a screening of some stocks globally that reflect some particular characteristics.Going into more detail, the main parameters that I set,...

By now, readers are undoubtedly familiar with the souring backdrop for tech stocks. From the stubbornly persistent inflation readings to the ongoing Russian-Ukraine conflict to the broadly...

Shares of Pfizer (NYSE:PFE) headed lower on Monday, after the pharmaceuticals giant announced on Friday that its coronavirus drug, Paxlovid, failed a late-stage trial when it didn't "meet its primary...

Rio Tinto (LON:RIO) has outperformed the NASDAQ QQQ over the past 5 years With slowing growth in demand for steel and falling prices, the outlook is not favorable RIO’s performance is largely...

InMed Pharmaceuticals Inc (NASDAQ:INM) continues its transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into the health and wellness market. Product launches...

Shares of Canopy Growth (NASDAQ:CGC) (TSX:WEED) have gained 14% in the past week after the cannabis grower publicly outlined a series of cost-reduction actions in an effort to accelerate its path to...